169 related articles for article (PubMed ID: 22511114)
21. New drugs for prostate cancer.
Alifrangis C; O'Hanlon-Brown C; Tuthill M; Waxman J
BJU Int; 2012 Jun; 109(12):1801-6. PubMed ID: 21933331
[TBL] [Abstract][Full Text] [Related]
22. Serum bone turnover markers (PINP and ICTP) for the early detection of bone metastases in patients with prostate cancer: a longitudinal approach.
Koopmans N; de Jong IJ; Breeuwsma AJ; van der Veer E
J Urol; 2007 Sep; 178(3 Pt 1):849-53; discussion 853; quiz 1129. PubMed ID: 17631330
[TBL] [Abstract][Full Text] [Related]
23. Treatment of prostate cancer in unfit senior adult patients.
Falci C; Morello E; Droz JP
Cancer Treat Rev; 2009 Oct; 35(6):522-7. PubMed ID: 19487081
[TBL] [Abstract][Full Text] [Related]
24. [What is safe in the therapy of advanced prostatic cancer?].
Gropp C; Burk K
Internist (Berl); 1985 Dec; 26(12):765-70. PubMed ID: 3936819
[No Abstract] [Full Text] [Related]
25. Impact of pretreatment factors, biopsy Gleason grade volume indices and post-treatment nadir PSA on overall survival in patients with metastatic prostate cancer treated with step-up hormonal therapy.
Miyamoto S; Ito K; Miyakubo M; Suzuki R; Yamamoto T; Suzuki K; Suzuki K; Yamanaka H
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):75-86. PubMed ID: 21986985
[TBL] [Abstract][Full Text] [Related]
26. Immunomagnetic quantification of circulating tumor cells as a prognostic factor of androgen deprivation responsiveness in patients with hormone naive metastatic prostate cancer.
Okegawa T; Nutahara K; Higashihara E
J Urol; 2008 Oct; 180(4):1342-7. PubMed ID: 18707699
[TBL] [Abstract][Full Text] [Related]
27. Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).
Kawakami J; Cowan JE; Elkin EP; Latini DM; DuChane J; Carroll PR;
Cancer; 2006 Apr; 106(8):1708-14. PubMed ID: 16544313
[TBL] [Abstract][Full Text] [Related]
28. Overview of hormonal therapy for prostate cancer.
Carter HB; Isaacs JT
Prog Clin Biol Res; 1990; 350():129-40. PubMed ID: 2201039
[No Abstract] [Full Text] [Related]
29. Hormone-refractory prostate cancer: a shifting paradigm in treatment.
Gallagher E; Gapstur R
Clin J Oncol Nurs; 2006 Apr; 10(2):233-40. PubMed ID: 16708706
[TBL] [Abstract][Full Text] [Related]
30. [Metastatic prostate cancer].
Droz JP; Flechon A; Terret C
Rev Prat; 2003 Dec; 53(20):2258-62. PubMed ID: 15018080
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive geriatric assessment basics for the cancer professional.
Extermann M
J Oncol Manag; 2003; 12(2):13-7. PubMed ID: 12699111
[TBL] [Abstract][Full Text] [Related]
32. Additive effect of zoledronic acid on serum prostate-specific antigen changes for hormone-sensitive prostate cancer patients with bone metastasis treated by combined androgen blockade.
Kamiya N; Suzuki H; Endo T; Takano M; Yano M; Naoi M; Nishimi D; Kawamura K; Imamoto T; Ichikawa T
Int J Urol; 2012 Feb; 19(2):169-73. PubMed ID: 22126137
[TBL] [Abstract][Full Text] [Related]
33. Chemotherapy of advanced cancer of the prostate.
Wirth MP
Prog Clin Biol Res; 1990; 350():159-70. PubMed ID: 2201042
[No Abstract] [Full Text] [Related]
34. Management of prostate cancer in the older man.
Mohile SG; Lachs M; Dale W
Semin Oncol; 2008 Dec; 35(6):597-617. PubMed ID: 19027464
[TBL] [Abstract][Full Text] [Related]
35. The treatment of hormone refractory prostate cancer.
Panvichian R; Pienta KJ
Compr Ther; 1996 Feb; 22(2):81-7. PubMed ID: 8689867
[No Abstract] [Full Text] [Related]
36. Maintaining bone health in prostate cancer throughout the disease continuum.
Saad F; Eastham J
Semin Oncol; 2010 Jun; 37 Suppl 1():S30-7. PubMed ID: 20682370
[TBL] [Abstract][Full Text] [Related]
37. [Geriatric assessment in the oncology setting].
Terret C
Bull Cancer; 2008 May; 95 FMC Onco():F16-20. PubMed ID: 18511362
[TBL] [Abstract][Full Text] [Related]
38. Choice of first-line treatment for metastatic prostate cancer.
Prescrire Int; 2013 Feb; 22(135):51. PubMed ID: 23444511
[No Abstract] [Full Text] [Related]
39. Prostate cancer.
Guthrie TH; Watson P
Am Fam Physician; 1987 Oct; 36(4):217-24. PubMed ID: 3314438
[TBL] [Abstract][Full Text] [Related]
40. [Metastatic prostate cancer treatment in the elderly].
Falandry C; Bonnefoy M; You B; Freyer G
Bull Cancer; 2007 Jul; 94(7 Suppl):F89-96. PubMed ID: 17845998
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
